G.ST Antivirals

Austria
Vienna, Vienna, Austria, 1030

Company profile

G.ST Antivirals company profile

G.ST Antivirals is a clinical-stage biotech company that applies an innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-10-01, Month

Headquarters

Postal code
1030
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$9.6M
Last funding
Series A / $6.7M / 2024-01-25
Last equity funding
Series A / $6.7M
Investors
2
Lead investors
1
Founders
2

Founders and investors

Founders

Guido GualdoniJohannes Stöckl

Lead investors

XISTA Science Ventures

Investors

Lansdowne PartnersXISTA Science Ventures